Skip to main content
Top
Published in: Lung 1/2017

01-02-2017

Influence of Gender on Epidemiology and Clinical Manifestations of Sarcoidosis: A Population-Based Retrospective Cohort Study 1976–2013

Authors: Patompong Ungprasert, Cynthia S. Crowson, Eric L. Matteson

Published in: Lung | Issue 1/2017

Login to get access

Abstract

Purpose

The influence of ethnicity on epidemiology and clinical manifestations of sarcoidosis is well recognized. However, data on the role of sex are limited.

Methods

The current study utilized the resource of the Rochester Epidemiology Project to identify all residents of Olmsted County, Minnesota, United States, with new diagnosis of sarcoidosis from 1976 to 2013. Diagnosis was verified by medical record and histopathological report review.

Results

345 incident cases of sarcoidosis were identified: 174 (50 %) were female and 171 (50 %) were male. The age at diagnosis was significantly higher among females than males (48.3 vs. 42.8 years; p < 0.001). Intra-thoracic disease was seen in the great majority of patients (98 % among females and 96 % among males; p = 0.50). However, pulmonary symptoms were significantly more frequent among males than females (51 vs. 36 %; p = 0.006). The frequency of individual extra-thoracic organ involvement was not significantly different between females and males except for cutaneous involvement and uveitis that were significantly more common among females (6 vs. 1 % for uveitis, p = 0.012 and 25 vs. 12 % for cutaneous involvement, p = 0.002). The frequency of elevate angiotensin-converting enzyme level and hypercalcemia was not significantly different between the two sexes.

Conclusions

Females tended to be older at the age they developed sarcoidosis, and had more uveitis and cutaneous involvement than males.
Literature
1.
go back to reference Newman LS, Rose CS, Bresnitz EA et al (2004) A case control etiologic study of sarcoidosis: environmental and occupational risk factors. Am J Respir Crit Care Med 170:1324–1330CrossRefPubMed Newman LS, Rose CS, Bresnitz EA et al (2004) A case control etiologic study of sarcoidosis: environmental and occupational risk factors. Am J Respir Crit Care Med 170:1324–1330CrossRefPubMed
2.
go back to reference Rybicki BA, Major M, Popovich J Jr et al (1997) Racial differences in sarcoidosis incidence: a 5-year study in a health maintenance organization. Am J Epidemiol 145:234–241CrossRefPubMed Rybicki BA, Major M, Popovich J Jr et al (1997) Racial differences in sarcoidosis incidence: a 5-year study in a health maintenance organization. Am J Epidemiol 145:234–241CrossRefPubMed
3.
go back to reference Cozier YC, Berman JS, Palmer JR et al (2011) Sarcoidosis in black women in the United States: data from the black women’s health study. Chest 139:144–150CrossRefPubMed Cozier YC, Berman JS, Palmer JR et al (2011) Sarcoidosis in black women in the United States: data from the black women’s health study. Chest 139:144–150CrossRefPubMed
4.
go back to reference Morimoto T, Azuma A, Abe S et al (2008) Epidemiology of sarcoidosis in Japan. Eur Resp J 31:372–379CrossRef Morimoto T, Azuma A, Abe S et al (2008) Epidemiology of sarcoidosis in Japan. Eur Resp J 31:372–379CrossRef
5.
go back to reference Westney GE, Judson MA (2006) Racial and ethnic disparities in sarcoidosis: from genetics to socioeconomics. Clin Chest Med 27:453–462CrossRefPubMed Westney GE, Judson MA (2006) Racial and ethnic disparities in sarcoidosis: from genetics to socioeconomics. Clin Chest Med 27:453–462CrossRefPubMed
6.
go back to reference Ortona E, Pierdominici M, Maselli A et al (2016) Sex-based differences in autoimmune diseases. Ann Ist Super Sanita 52:205–212PubMed Ortona E, Pierdominici M, Maselli A et al (2016) Sex-based differences in autoimmune diseases. Ann Ist Super Sanita 52:205–212PubMed
7.
go back to reference Rocca WA, Yawn BP, St Sauver JL et al (2012) History of the rochester epidemiology project: half a century of medical records linkage in a U.S. population. Mayo Clin Proc 87:1202–1213CrossRefPubMedPubMedCentral Rocca WA, Yawn BP, St Sauver JL et al (2012) History of the rochester epidemiology project: half a century of medical records linkage in a U.S. population. Mayo Clin Proc 87:1202–1213CrossRefPubMedPubMedCentral
8.
go back to reference Costabel U, Hunninghake GW (1999) ATS/ERS/WASOG statement on sarcoidosis. Sarcoidosis statement committee. American Thoracic Society. European Respiratory Society. World association for sarcoidosis and other granulomatous disorders. Eur Respir J 14:735–737CrossRefPubMed Costabel U, Hunninghake GW (1999) ATS/ERS/WASOG statement on sarcoidosis. Sarcoidosis statement committee. American Thoracic Society. European Respiratory Society. World association for sarcoidosis and other granulomatous disorders. Eur Respir J 14:735–737CrossRefPubMed
9.
go back to reference Birnbaum AD, Rifkin LM (2014) Sarcoidosis: sex dependent variations in presentation and management. J Opthalmol 2014:236905 Birnbaum AD, Rifkin LM (2014) Sarcoidosis: sex dependent variations in presentation and management. J Opthalmol 2014:236905
10.
go back to reference Brito-Zeron P, Sellares J, Bosch X et al (2016) Epidemiologic patterns of disease expression in sarcoidosis: age, gender and ethnicity-related differences. Clin Exp Rheumatol 34:380–388PubMed Brito-Zeron P, Sellares J, Bosch X et al (2016) Epidemiologic patterns of disease expression in sarcoidosis: age, gender and ethnicity-related differences. Clin Exp Rheumatol 34:380–388PubMed
11.
go back to reference Judson MA, Boan AD, Lackland DT (2012) The clinical course of sarcoidosis: presentation, diagnosis, and treatment in a large white and black cohort in the United States. Sarcoidosis Vasc Diffus Lung Dis 29:119–127 Judson MA, Boan AD, Lackland DT (2012) The clinical course of sarcoidosis: presentation, diagnosis, and treatment in a large white and black cohort in the United States. Sarcoidosis Vasc Diffus Lung Dis 29:119–127
12.
go back to reference Birnbaum AD, Oh FS, Ckakrabarti A et al (2011) Clinical features and diagnostic evaluation of biopsy-proven ocular sarcodiosis. Arch Ophthalmol 129:409–413CrossRefPubMed Birnbaum AD, Oh FS, Ckakrabarti A et al (2011) Clinical features and diagnostic evaluation of biopsy-proven ocular sarcodiosis. Arch Ophthalmol 129:409–413CrossRefPubMed
13.
go back to reference Yanardag H, Nuri Pamuk O, Karayel T (2003) Cutaneous involvement in sarcoidosis: analysis of the features in 170 patients. Respir Med 97:978–982CrossRefPubMed Yanardag H, Nuri Pamuk O, Karayel T (2003) Cutaneous involvement in sarcoidosis: analysis of the features in 170 patients. Respir Med 97:978–982CrossRefPubMed
Metadata
Title
Influence of Gender on Epidemiology and Clinical Manifestations of Sarcoidosis: A Population-Based Retrospective Cohort Study 1976–2013
Authors
Patompong Ungprasert
Cynthia S. Crowson
Eric L. Matteson
Publication date
01-02-2017
Publisher
Springer US
Published in
Lung / Issue 1/2017
Print ISSN: 0341-2040
Electronic ISSN: 1432-1750
DOI
https://doi.org/10.1007/s00408-016-9952-6

Other articles of this Issue 1/2017

Lung 1/2017 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.